| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 8.516 | 121.111 | 147.982 |
| Total Income - EUR | - | - | - | - | - | - | - | 49.295 | 134.872 | 148.007 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 26.289 | 119.780 | 152.704 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 23.007 | 15.092 | -4.697 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 22.921 | 14.024 | -8.081 |
| Employees | - | - | - | - | - | - | - | 3 | 3 | 2 |
Check the financial reports for the company - Hexy Vet Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 18.277 | 16.015 | 12.331 |
| Current Assets | - | - | - | - | - | - | - | 28.999 | 30.555 | 36.072 |
| Inventories | - | - | - | - | - | - | - | 6.229 | 26.017 | 31.099 |
| Receivables | - | - | - | - | - | - | - | 14.763 | -1.358 | 4.515 |
| Cash | - | - | - | - | - | - | - | 8.007 | 5.896 | 459 |
| Shareholders Funds | - | - | - | - | - | - | - | 23.124 | 37.078 | 25.290 |
| Social Capital | - | - | - | - | - | - | - | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | - | 10.559 | 9.492 | 23.113 |
| Income in Advance | - | - | - | - | - | - | - | 13.593 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Hexy Vet Pharma S.r.l.